For years, MASH was where drug development dreams went to die.  | After Rezdiffra’s approval and Wegovy’s label expansion, ...

From sales to compliance, AI agents promise to augment workforce capabilities, streamline workflows, and enhance productivity ...

Novo Nordisk has appointed U.S. pharmaceutical executive Greg Miley as its new head of corporate affairs, as the obesity ...

Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered discounts ...

Rani Therapeutics on Friday announced a licensing deal to develop and sell an oral version of Chugai Pharmaceutical's ...

The latest strand in Pelage Pharmaceuticals’ growing funds comes from a $120 million series B fundraising round that the ...

The Trump administration has struck a deal with EMD Serono to lower drug prices — part of a larger push from the ...

Dianthus Therapeutics and Boehringer Ingelheim headlined the latest round of licensing d | Dianthus and Boehringer Ingelheim ...

New Jersey gubernatorial hopeful Mikie Sherrill took in over $25,000 in campaign donor cash from pharma giants accused of ...

As part of the FDA's rolling review of the biologics license application, Vertex expects to submit the first module to the regulator for potential accelerated approval before the end of 2025, and said ...

Medicus Pharma has carved out a niche in dermatological therapeutics, focusing on novel compounds and delivery systems ...

Roche (RHHBY) stock is in focus as the company secures global rights (excluding Greater China) to Hansoh's HS-20110, an ...